Amarin's Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion
Analysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF) and Amarin (AMRN)
Amarin Corp Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Ocular Therapeutix (OCUL) and Amarin (AMRN)
Jefferies Downgrades Amarin Corp to Hold, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Goldman Sachs Maintains Sell on Amarin Corp, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Northland Capital Markets Maintains Market Perform on Amarin Corp, Lowers Price Target to $1.25
Amarin Corp Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN) and Myriad Genetics (MYGN)
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN), Ascendis Pharma (ASND) and MoonLake Immunotherapeutics (MLTX)
SVB Securities Sticks to Their Hold Rating for Amarin (AMRN)
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)
Jefferies Upgrades Amarin Corp to Buy, Raises Price Target to $3
H.C. Wainwright Remains a Hold on Amarin (AMRN)
SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating
SVB Leerink Maintains Market Perform on Amarin Corp, Lowers Price Target to $2
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amarin (AMRN) and Travere Therapeutics (TVTX)
No Data